Sotera Health Company (SHC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sotera Health Company (SHC:NASDAQ), powered by AI.

Current Price
$16.19
P/E Ratio
59.0
Market Cap
4.6B
Sector
Healthcare
What is the Sotera Health Company stock price forecast?

Sotera Health Company is currently trading at $16.19. View real-time AI analysis on Alpha Lenz.

What is Sotera Health Company insider trading activity?

View the latest insider trading data for Sotera Health Company on Alpha Lenz.

What is Sotera Health Company's P/E ratio?

Sotera Health Company's P/E ratio is 59.0.

Sotera Health Company

NASDAQ · SHC
$16.19-0.20(-1.22%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Sotera Health Company's future dividend policy...
Alpha Chat Insight

Sotera Health Company trades at a P/E of 59.0 (premium valuation) with strong ROE of 15.4%. Operating margin of 31.1% indicates strong profitability.

Ask for details

Company Overview

Sotera Health Company is a leading provider of mission-critical health and sterilization services. It plays a vital role in ensuring safety and compliance across medical device, pharmaceutical, food, and other industries that require stringent sterilization and laboratory testing services. The company operates under three key business units: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides end-to-end sterilization solutions using innovative technologies to eliminate pathogens from medical and other consumable products. Nordion is instrumental in supplying Cobalt-60 that facilitates the radiation sterilization process, essential for medical devices, pharmaceuticals, and food safety industries. Nelson Labs delivers comprehensive testing and consultancy services, supporting organizations in gaining and maintaining regulatory approvals. Sotera Health's integrated solutions are crucial for maintaining public health standards and meeting regulatory compliance, making it an indispensable entity in the global health landscape. As an established operator with a broad international presence, Sotera Health Company underscores the importance of safety and reliability in its service offerings, significantly impacting industries reliant on rigorous safety standards.

CEOMr. Michael B. Petras Jr.
SectorHealthcare
IndustryDiagnostics & Research
Employees3,000

Company Statistics

FY 2025

Profile

$4.60BMarket Cap
$1.16BRevenue
0.00Shares Out
3,000Employees

Margins

55.48%Gross
43.60%EBITDA
31.11%Operating
12.68%Pre-Tax
6.70%Net

Valuation

58.98P/E
7.59P/B
3.95EV/Sales
12.87EV/EBITDA
30.82P/FCF

Growth (CAGR)

5.05%Rev 3Yr
7.30%Rev 5Yr
13.39%Op Inc 3Yr
11.94%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

2.46%ROA
15.42%ROE
9.57%ROIC

Financial Health

$344.62MCash & Cash Equivalents
$2.31BNet Debt
438.45%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sotera Health Company (ticker: SHC) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 3,000 employees. Market cap is $4.6B.

The current price is $16.19 with a P/E ratio of 58.98x and P/B of 7.59x.

ROE is 15.42% and operating margin is 31.11%. Annual revenue is $1.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sotera Health Company (SHC) Stock Forecast 2026 $16.19 — Price, Financials & Analyst Targets | Alpha Lenz